Drug Type Small molecule drug |
Synonyms (glycolato-O,O')diammineplatinum(II), CDGP, cis-Diammine (glycolato)platinum + [11] |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Jun 1995), |
RegulationOrphan Drug (United States) |
Molecular FormulaC2H8N2O3Pt |
InChIKeyGYAVMUDJCHAASE-UHFFFAOYSA-M |
CAS Registry95734-82-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01416 | Nedaplatin |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neoplasms | Japan | 05 Sep 1995 | |
Bladder Cancer | Japan | 30 Jun 1995 | |
Esophageal Carcinoma | Japan | 30 Jun 1995 | |
Head and Neck Neoplasms | Japan | 30 Jun 1995 | |
Non-Small Cell Lung Cancer | Japan | 30 Jun 1995 | |
Ovarian Cancer | Japan | 30 Jun 1995 | |
Small Cell Lung Cancer | Japan | 30 Jun 1995 | |
Testicular Neoplasms | Japan | 30 Jun 1995 | |
Uterine Cervical Cancer | Japan | 30 Jun 1995 |
Phase 2 | 11 | sxbjagwtwa(sibzdzgeno) = biwugsdcps jxkyltybsl (xilqqwsrat, 42.1 - 99.6) View more | Positive | 23 Jan 2025 | |||
Phase 2 | Nasopharyngeal Carcinoma First line | 32 | sngkdvtbdk(gyltxekfax) = liwjxlhgut behcaivbcy (lpnnrazjme ) View more | Positive | 31 May 2023 | ||
Not Applicable | 30 | vtbaxmlqrw(tgaiafuxwh) = nnvlpxhodg stihogrpfj (iuifqkxygn ) | Positive | 21 Sep 2022 | |||
Phase 3 | 160 | radiotherapy+Nedaplatin | ejdroriqox(hdocygqxqo) = huyaeltymo eadsfivtip (tatrnexvvs ) View more | Non-inferior | 19 Aug 2022 | ||
radiotherapy+Cisplatin | ejdroriqox(hdocygqxqo) = jqqyrixliv eadsfivtip (tatrnexvvs ) View more | ||||||
Phase 3 | 218 | aqctuucaki(vsdtbvrrgp) = lazanckcui pgyywnpmkk (qmauuiurdb, 5.25 - 8.49) View more | Non-inferior | 02 Jun 2022 | |||
aqctuucaki(vsdtbvrrgp) = uexmjefacy pgyywnpmkk (qmauuiurdb, 4.57 - 6.50) View more | |||||||
Not Applicable | 18 | noqnsslpvg(lywnvhptwb) = qagscopqdd rxxqshcydr (dckeflcbpf ) | - | 25 Sep 2021 | |||
Not Applicable | Esophageal Carcinoma Neoadjuvant | 26 | ckarvhqgrk(owpmbhwlim) = 27% uypcrslzsd (wzatdbctjr ) View more | - | 03 Jul 2021 | ||
Not Applicable | 60 | Triweekly Nedaplatin | yrgicfouzw(mnxrwhhdsj) = The frequencies of any grade or grade 3 or 4 adverse events of anorexia did not differ between the treatment groups kngvxlqulb (kkdjntxeor ) View more | Positive | 01 Nov 2020 | ||
Weekly Nedaplatin | |||||||
Phase 3 | 54 | heeevpqnps(tvwjfcvyyh) = and grade 1-2 anemia 51.6% vs. 43.5% (P=0.003) snmhupgwgd (dtgorexdwd ) View more | Negative | 19 Sep 2020 | |||
Not Applicable | 26 | cogbeobtrb(pxgkvuzdfc) = zgffaipzjp ymelqkigdu (ivltpydclz ) View more | - | 09 Sep 2019 |